NEW YORK, May 18, 2025 (GLOBE NEWSWIRE) — Pomerantz LLP is investigating claims on behalf of investors of Bausch + Lomb Corporation (“Bausch + Lomb” or the “Company”) (NYSE: BLCO). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.
The investigation concerns whether Bausch + Lomb and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices.
[Click here for information about joining the class action]
On March 27, 2025, Bausch + Lomb announced a voluntary recall of intraocular lenses on its enVista platform due to reports of toxic anterior segment syndrome, a potential complication in cataract surgery.
On this news, Bausch + Lomb’s stock price fell $1.54 per share, or 9.83%, over the following two trading sessions, to close at $14.13 per share on March 28, 2025.
Then, on April 30, 2025, Bausch + Lomb issued a press release reporting its financial results for the first quarter of 2025. Among other items, Bausch + Lomb reported an adjusted net loss of $54 million, compared to $24 million in adjusted net income for the same period in 2024. The Company also lowered its full-year growth outlook to a range of 4.5% to 6.5% year-over-year, compared to its previous guidance of 5.5% to 7.5%, citing the impact of the enVista product recall, among other factors.
On this news, Bausch + Lomb’s stock price fell $2.16 per share, or 15.74%, to close at $11.56 per share on April 30, 2025.
Pomerantz LLP, with offices in New York, Chicago, Los Angeles, London, Paris, and Tel Aviv, is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation. Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, Pomerantz pioneered the field of securities class actions. Today, more than 85 years later, Pomerantz continues in the tradition he established, fighting for the rights of the victims of securities fraud, breaches of fiduciary duty, and corporate misconduct. The Firm has recovered numerous multimillion-dollar damages awards on behalf of class members. See www.pomlaw.com.
Attorney advertising. Prior results do not guarantee similar outcomes.
CONTACT:
Danielle Peyton
Pomerantz LLP
dpeyton@pomlaw.com
646-581-9980 ext. 7980
- Premier Health Announces a Strategic Review Process to Enhance Shareholder Value - June 19, 2025
- Silly Nice Launches High-THC Full Spectrum Weed Drops Across New York Just in Time for Summer - June 19, 2025
- Making Waves for Marine Life: New York Marine Rescue Center and Canon Celebrate World Sea Turtle Day with Conservation and Education - June 19, 2025
